Cargando…

Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis

Dermatomyositis is an inflammatory myopathy characterized by symmetrical proximal muscle weakness and skin changes. Muscle biopsy hallmarks include perifascicular atrophy, loss of intramuscular capillaries, perivascular and perimysial inflammation and the overexpression of IFN-inducible genes. Among...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luna, Noemí, Suárez-Calvet, Xavier, Lleixà, Cinta, Diaz-Manera, Jordi, Olivé, Montse, Illa, Isabel, Gallardo, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561123/
https://www.ncbi.nlm.nih.gov/pubmed/28819164
http://dx.doi.org/10.1038/s41598-017-09309-8
_version_ 1783257780301332480
author De Luna, Noemí
Suárez-Calvet, Xavier
Lleixà, Cinta
Diaz-Manera, Jordi
Olivé, Montse
Illa, Isabel
Gallardo, Eduard
author_facet De Luna, Noemí
Suárez-Calvet, Xavier
Lleixà, Cinta
Diaz-Manera, Jordi
Olivé, Montse
Illa, Isabel
Gallardo, Eduard
author_sort De Luna, Noemí
collection PubMed
description Dermatomyositis is an inflammatory myopathy characterized by symmetrical proximal muscle weakness and skin changes. Muscle biopsy hallmarks include perifascicular atrophy, loss of intramuscular capillaries, perivascular and perimysial inflammation and the overexpression of IFN-inducible genes. Among them, the retinoic-acid inducible gene 1 (RIG-I) is specifically overexpressed in perifascicular areas of dermatomyositis muscle. The aim of this work was to study if RIG-I expression may be modulated by hypoxia using an in vitro approach. We identified putative hypoxia response elements (HRE) in RIG-I regulatory regions and luciferase assays confirmed that RIG-I is a new HIF-inducible gene. We observed an increase expression of RIG-I both by Real time PCR and Western blot in hypoxic conditions in human muscle cells. Cell transfection with a constitutive RIG-I expression vector increased levels of phospho-IRF-3, indicating that RIG-I promotes binding of transcription factors to the enhancer sequence of IFN. Moreover, release of IFN-β was observed in hypoxic conditions. Finally, HIF-1α overexpression was confirmed in the muscle biopsies and in some RIG-I positive perifascicular muscle fibres but not in controls. Our results indicate that hypoxia triggers the production of IFN-I in vitro, and may contribute to the pathogenesis of DM together with other inflammatory factors.
format Online
Article
Text
id pubmed-5561123
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55611232017-08-18 Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis De Luna, Noemí Suárez-Calvet, Xavier Lleixà, Cinta Diaz-Manera, Jordi Olivé, Montse Illa, Isabel Gallardo, Eduard Sci Rep Article Dermatomyositis is an inflammatory myopathy characterized by symmetrical proximal muscle weakness and skin changes. Muscle biopsy hallmarks include perifascicular atrophy, loss of intramuscular capillaries, perivascular and perimysial inflammation and the overexpression of IFN-inducible genes. Among them, the retinoic-acid inducible gene 1 (RIG-I) is specifically overexpressed in perifascicular areas of dermatomyositis muscle. The aim of this work was to study if RIG-I expression may be modulated by hypoxia using an in vitro approach. We identified putative hypoxia response elements (HRE) in RIG-I regulatory regions and luciferase assays confirmed that RIG-I is a new HIF-inducible gene. We observed an increase expression of RIG-I both by Real time PCR and Western blot in hypoxic conditions in human muscle cells. Cell transfection with a constitutive RIG-I expression vector increased levels of phospho-IRF-3, indicating that RIG-I promotes binding of transcription factors to the enhancer sequence of IFN. Moreover, release of IFN-β was observed in hypoxic conditions. Finally, HIF-1α overexpression was confirmed in the muscle biopsies and in some RIG-I positive perifascicular muscle fibres but not in controls. Our results indicate that hypoxia triggers the production of IFN-I in vitro, and may contribute to the pathogenesis of DM together with other inflammatory factors. Nature Publishing Group UK 2017-08-17 /pmc/articles/PMC5561123/ /pubmed/28819164 http://dx.doi.org/10.1038/s41598-017-09309-8 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
De Luna, Noemí
Suárez-Calvet, Xavier
Lleixà, Cinta
Diaz-Manera, Jordi
Olivé, Montse
Illa, Isabel
Gallardo, Eduard
Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis
title Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis
title_full Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis
title_fullStr Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis
title_full_unstemmed Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis
title_short Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis
title_sort hypoxia triggers ifn-i production in muscle: implications in dermatomyositis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561123/
https://www.ncbi.nlm.nih.gov/pubmed/28819164
http://dx.doi.org/10.1038/s41598-017-09309-8
work_keys_str_mv AT delunanoemi hypoxiatriggersifniproductioninmuscleimplicationsindermatomyositis
AT suarezcalvetxavier hypoxiatriggersifniproductioninmuscleimplicationsindermatomyositis
AT lleixacinta hypoxiatriggersifniproductioninmuscleimplicationsindermatomyositis
AT diazmanerajordi hypoxiatriggersifniproductioninmuscleimplicationsindermatomyositis
AT olivemontse hypoxiatriggersifniproductioninmuscleimplicationsindermatomyositis
AT illaisabel hypoxiatriggersifniproductioninmuscleimplicationsindermatomyositis
AT gallardoeduard hypoxiatriggersifniproductioninmuscleimplicationsindermatomyositis